Cargando…

P2Y(12) Platelet Receptors: Importance in Percutaneous Coronary Intervention

Apart from their role in hemostasis and thrombosis, platelets are involved in many other biological processes such as wound healing and angiogenesis. Percutaneous coronary intervention is a highly thrombogenic procedure inducing platelets and monocytes activation through endothelial trauma and conta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falcão, Felipe Jose de Andrade, Carvalho, Leonardo, Chan, Mark, Alves, Cláudia Maria Rodrigues, Carvalho, Antônio Carlos Camargo, Caixeta, Adriano Mendes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032309/ https://www.ncbi.nlm.nih.gov/pubmed/23917456 http://dx.doi.org/10.5935/abc.20130162

Ejemplares similares

Relation between the ankle-brachial index and the complexity of coronary artery disease in older patients
por: de Andrade Falcão, Felipe José, et al.
Publicado: (2013)

Single vascular access for concomitant percutaneous coronary intervention and left ventricular assistance with Impella
por: Lyra, Flávio, et al.
Publicado: (2021)

Chronic Total Occlusion Recanalization Concurrent to Culprit Primary Percutaneous Coronary Intervention via Distal Transradial Access: Maximizing Revascularization Through Minimalist Approach
por: Oliveira, Marcos Danillo Peixoto, et al.
Publicado: (2021)

Changes in neutrophil-lymphocyte and platelet-lymphocyte ratios before and after percutaneous coronary intervention and their impact on the prognosis of patients with acute coronary syndrome
por: Souza Teixeira, Edenilson de, et al.
Publicado: (2023)

The Importance of the First Jordanian Percutaneous Coronary Intervention Registry
por: Al-Suwaidi, Jassim
Publicado: (2017)

Importance of Hospital Entry: Walk-in STEMI and Primary Percutaneous Coronary Intervention
por: Bansal, Eric, et al.
Publicado: (2014)

Contrast-induced thrombocytopenia following percutaneous coronary intervention
por: Ferreira, Roberto Muniz, et al.
Publicado: (2017)

Platelet Reactivity Was Not Associated with Infarct Size after Primary Percutaneous Coronary Intervention
por: Park, Seohwa, et al.
Publicado: (2021)

Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention
por: Lianos, Ioannis, et al.
Publicado: (2022)

High On-Treatment Platelet Reactivity in Patients Undergoing Complex Percutaneous Coronary Interventions
por: Urban, Lukáš, et al.
Publicado: (2023)

Predictors of in-hospital mortality in patients with ST-segment elevation myocardial infarction undergoing pharmacoinvasive treatment
por: de Andrade Falcão, Felipe José, et al.
Publicado: (2013)

Differences in Optimal Platelet Reactivity after Potent P2Y12 Inhibitor Treatment in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
por: Song, Kai, et al.
Publicado: (2022)

Distal transradial access for post-CABG coronary and surgical grafts angiography and interventions
por: Oliveira, Marcos Danillo P., et al.
Publicado: (2021)

Thrombus aspiration during primary percutaneous coronary intervention associated with reduced platelet activation
por: Sahin, Muslum, et al.
Publicado: (2015)

High platelet reactivity affects the clinical outcomes of patients undergoing percutaneous coronary intervention
por: Zhang, Jun-Jie, et al.
Publicado: (2016)

Obstructive Sleep Apnea Affecting Platelet Reactivity in Patients Undergoing Percutaneous Coronary Intervention
por: Jiang, Xiao-Min, et al.
Publicado: (2018)

Prognostic value of mean platelet volume in patients undergoing elective percutaneous coronary intervention
por: Seyyed-Mohammadzad, Mir Hossein, et al.
Publicado: (2015)

An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary intervention
por: Wang, Jing, et al.
Publicado: (2021)

P2Y12 blocker monotherapy after percutaneous coronary intervention
por: Verheugt, F. W. A., et al.
Publicado: (2021)

P2Y(12) Inhibitor Monotherapy after Percutaneous Coronary Intervention
por: Zhou, Xuan, et al.
Publicado: (2022)

Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention
por: Aradi, Dániel, et al.
Publicado: (2014)

Association between baseline platelet count and severe adverse outcomes following percutaneous coronary intervention
por: Cheng, Wan–Jun, et al.
Publicado: (2018)

4061 Clinical utility of precision medicine approaches to guide anti-platelet selection for adult patients with acute coronary syndromes (ACS), following percutaneous coronary intervention (PCI)
por: Mosley, Scott, et al.
Publicado: (2020)

Cardiogenic shock after ST elevation myocardial infarction and IABP-SHOCK II risk score validation in a cohort treated with pharmacoinvasive strategy
por: Moraes, Pedro Ivo M, et al.
Publicado: (2019)

Bivalirudin in percutaneous coronary intervention
por: Lehman, Sam J, et al.
Publicado: (2006)

Percutaneous Coronary Intervention in the Elderly
por: Walsh, Simon J, et al.
Publicado: (2007)

Percutaneous Coronary Interventions in Women
por: Joodi, Golsa, et al.
Publicado: (2023)

Safety of cangrelor and transition to oral P2Y(12) inhibitors in patients undergoing percutaneous coronary intervention: the ARCANGELO study
por: De Luca, Leonardo, et al.
Publicado: (2023)

Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention
por: Kwan, Joanne, et al.
Publicado: (2011)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Relationship between platelet aggregation and stroke risk after percutaneous coronary intervention: a PENDULUM analysis
por: Matsumaru, Yuji, et al.
Publicado: (2022)

Intolerance to Multiple P2Y12 Inhibitors Following Percutaneous Coronary Intervention
por: Shnoda, Mina, et al.
Publicado: (2021)

De-escalation of anti-platelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a narrative review
por: Han, Ya-Ling
Publicado: (2019)

Long-term effects of baseline on-treatment platelet reactivity in patients with acute coronary syndrome and thrombocytopenia undergoing percutaneous coronary intervention
por: Liu, Ru, et al.
Publicado: (2022)

Inter-Ethnic Differences in Quantified Coronary Artery Disease Severity and All-Cause Mortality among Dutch and Singaporean Percutaneous Coronary Intervention Patients
por: Gijsberts, Crystel M., et al.
Publicado: (2015)

Clopidogrel versus ticagrelor in the treatment of Chinese patients undergoing percutaneous coronary intervention: effects on platelet function assessed by platelet function tests and mean platelet volume
por: Zhang, Yang, et al.
Publicado: (2021)

The importance of left ventricular function for long-term outcome after primary percutaneous coronary intervention
por: van der Vleuten, Pieter A, et al.
Publicado: (2008)

Platelet microRNA-15b protects against high platelet reactivity in patients undergoing percutaneous coronary intervention through Bcl-2-mediated platelet apoptosis
por: Wang, Jinghan, et al.
Publicado: (2020)

High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel
por: Geisler, Tobias, et al.
Publicado: (2015)

Changes in the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios before and after percutaneous coronary intervention and their impact on the prognosis of patients with acute coronary syndrome
por: Sheng, Jianlong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sc75co59er8f1nispvd1ef8o0t